NeuroBo Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 08/12/2022 | 493,995 | $237,000 | 0.00% | 1.85% |
| MURCHINSON LTD. | 08/15/2022 | 205,256 | $98,000 | 0.00% | 0.77% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2022 | 108,541 | $51,000 | 100.00% | 0.41% |
| SABBY MANAGEMENT, LLC | 08/15/2022 | 93,376 | $45,000 | -74.97% | 0.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2022 | 65,290 | $30,000 | 0.00% | 0.24% |
| RENAISSANCE TECHNOLOGIES LLC | 08/12/2022 | 59,356 | $28,000 | 100.00% | 0.22% |
| MOUNT YALE INVESTMENT ADVISORS, LLC | 08/02/2022 | 57,425 | $28,000 | 0.00% | 0.22% |
| TWO SIGMA SECURITIES, LLC | 08/15/2022 | 40,496 | $19,000 | 296.86% | 0.15% |
| MILLENNIUM MANAGEMENT LLC | 08/15/2022 | 24,056 | $11,000 | 100.00% | 0.09% |
| BLACKROCK INC. | 08/12/2022 | 21,257 | $10,000 | -51.78% | 0.08% |
| NORTHERN TRUST CORP | 08/12/2022 | 17,155 | $8,000 | 0.00% | 0.06% |
| STATE STREET CORP | 08/15/2022 | 16,558 | $8,000 | 0.00% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/15/2022 | 14,720 | $7,000 | 852.13% | 0.06% |
| CITADEL ADVISORS LLC | 08/15/2022 | 13,500 | $6,000 | -14.01% | 0.05% |
| UBS GROUP AG | 08/10/2022 | 3,066 | $1,000 | -72.75% | 0.01% |
| CAPTRUST FINANCIAL ADVISORS | 08/23/2022 | 3,044 | $1,000 | 0.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 08/11/2022 | 438 | $0 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/12/2022 | 356 | $0 | 1.71% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/12/2022 | 240 | $0 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/15/2022 | 166 | $0 | 0.00% | 0.00% |
| MORGAN STANLEY | 10/27/2022 | 76 | $0 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 08/09/2022 | 29 | $0 | 100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 08/09/2022 | 0 | $0 | 0.00% | 0.00% |
| SIMPLEX TRADING, LLC | 08/03/2022 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 08/16/2022 | 0 | $0 | -100.00% | 0.00% |
| HEMINGTON WEALTH MANAGEMENT | 07/22/2022 | 0 | $0 | -100.00% | 0.00% |
NeuroBo Pharmaceuticals, Inc.institutional Ownership - FAQ's
What percentage of NeuroBo Pharmaceuticals, Inc. stock is owned by
institutional investors?
4.59% of NeuroBo Pharmaceuticals, Inc. stock is owned by institutional investors.